Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Dec 8;132(48):17118-29.
doi: 10.1021/ja1045428. Epub 2010 Nov 11.

Sulfur versus iron oxidation in an iron-thiolate model complex

Affiliations
Comparative Study

Sulfur versus iron oxidation in an iron-thiolate model complex

Aidan R McDonald et al. J Am Chem Soc. .

Abstract

In the absence of base, the reaction of [Fe(II)(TMCS)]PF6 (1, TMCS = 1-(2-mercaptoethyl)-4,8,11-trimethyl-1,4,8,11-tetraazacyclotetradecane) with peracid in methanol at -20 °C did not yield the oxoiron(IV) complex (2, [Fe(IV)(O)(TMCS)]PF6), as previously observed in the presence of strong base (KO(t)Bu). Instead, the addition of 1 equiv of peracid resulted in 50% consumption of 1. The addition of a second equivalent of peracid resulted in the complete consumption of 1 and the formation of a new species 3, as monitored by UV-vis, ESI-MS, and Mössbauer spectroscopies. ESI-MS showed 3 to be formulated as [Fe(II)(TMCS) + 2O](+), while EXAFS analysis suggested that 3 was an O-bound iron(II)-sulfinate complex (Fe-O = 1.95 Å, Fe-S = 3.26 Å). The addition of a third equivalent of peracid resulted in the formation of yet another compound, 4, which showed electronic absorption properties typical of an oxoiron(IV) species. Mössbauer spectroscopy confirmed 4 to be a novel iron(IV) compound, different from 2, and EXAFS (Fe═O = 1.64 Å) and resonance Raman (ν(Fe═O) = 831 cm(-1)) showed that indeed an oxoiron(IV) unit had been generated in 4. Furthermore, both infrared and Raman spectroscopy gave indications that 4 contains a metal-bound sulfinate moiety (ν(s)(SO2) ≈ 1000 cm (-1), ν(as)(SO2) ≈ 1150 cm (-1)). Investigations into the reactivity of 1 and 2 toward H(+) and oxygen atom transfer reagents have led to a mechanism for sulfur oxidation in which 2 could form even in the absence of base but is rapidly protonated to yield an oxoiron(IV) species with an uncoordinated thiol moiety that acts as both oxidant and substrate in the conversion of 2 to 3.

PubMed Disclaimer

Figures

Figure 1
Figure 1
UV-Vis spectral changes upon titration of 1 with m-CPBA in MeOH. Red solid line: 0 equiv.; red dashed line: 1 equiv.; green dashed line: 2 equiv. to form 3; blue solid line: 3 equiv. to form 4.
Figure 2
Figure 2
Plot of titration of oxidant (m-CPBA) with 1 (0.85 mM) against intensity of absorption features assigned to 1 (•, λmax = 320 nm, left) and 4 (■, λmax = 830 nm, right).
Figure 3
Figure 3
The 4.2-K Mössbauer spectra of 1, 3, and 4 recorded in zero field (1.5 mM Fe, MeOH solvent). Spectra are shown as hash-marks, while spectral simulations are shown as lines: (A) 1; (B) 1 + 1 equiv. m-CPBA (50% 1, 50% 3); (C) 1 + 2 equiv. m-CPBA (92% 3, 8% 5); (D) 1 + 3 equiv. m-CPBA (86% 4, 14% 3)
Figure 4
Figure 4
ESI-MS spectra following the conversion of 1 (m/z = 357.1) to 3 (389.2) and 4 (405.2): (A) 1; (B) 1 + 1 equiv. m-CPBA; (C) 1 + 2 equiv. m-CPBA; (D) 1 + 3 equiv. m-CPBA
Figure 5
Figure 5
Resonance Raman spectrum of 4 obtained from an 8 mM CH3CN frozen solution of 4 using 406.7 nm excitation (10 mW power, 32 scans of 16 s each). S = solvent peak.
Figure 6
Figure 6
ORTEP plot of 6 (50% probability level). Hydrogen atoms and the O2SPh counteranion omitted for clarity. Selected inter-atomic distances (Å): Fe–O1, 1.996(2); Fe–S1, 3.1749(9); Fe–S2, 5.3605(11).
Figure 7
Figure 7
Comparison of the Fe K-edge X-ray absorption edge and pre-edge (inset) features of species 1 (black, –––), 3 (red, formula image), 4 (green, formula image), and 6 (blue, — — —).
Figure 8
Figure 8
Fourier transforms of the Fe K-edge EXAFS data (k3χ(k)) and unfiltered EXAFS spectra (k3χ(k), inset) obtained for 1, 3, 4, and 6. Experimental data is shown with dotted lines (•••••), while fits are shown with solid lines (——). Fourier transformation ranges are as follows: k = 2 – 15 Å−1 (1), k = 2 – 14 Å−1 (3), k = 2 – 14.95 Å−1 (4), k = 2 – 14.3 Å−1 (6). Fit parameters are shown in bold italics in Table 4.
Figure 9
Figure 9
ESI-MS spectra of compound 7 (A) and after reaction with 2 equiv. m-CPBA (B).
Figure 10
Figure 10
UV-vis spectral changes observed in the reaction of 2 (0.5 mmol/L, blue solid line) with 6 equivalents PhCO2H in MeOH at −20 °C over a 3-min period yielding a mixture of compounds 3 and 5 (yellow solid line).
Figure 11
Figure 11
4.2 K Mössbauer spectrum obtained after adding ~6 equivalents pyridinium triflate at −40 °C to 1.3 mM 2. 38% of the iron belongs to complex 5 and 47% to 3; the remainder of the iron belongs to broad and unresolved FeIII species.
Scheme 1
Scheme 1
Structures of 1, 2, and some synthetic oxoiron(IV) complexes (TMC, TPA, N4Py).
Scheme 2
Scheme 2
Reaction of 1 with m-CPBA.
Scheme 3
Scheme 3
Postulated mechanism for the conversion of 1 to 3 in the reaction between 1 and m-CPBA without added base. m-CPBA could react either at the iron site (pathway A) or the sulfur site (pathway B) of 1, evidence for both pathways is provided.

Similar articles

Cited by

References

    1. Groves JT. J. Inorg. Biochem. 2006;100:434–447. - PubMed
    2. Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG. Science. 2000;287:1615–1622. - PubMed
    1. Auclair K, Moënne-Loccoz P, Ortiz de Montellano PR. J. Am. Chem. Soc. 2001;123:4877–4885. - PubMed
    2. Ogliaro F, de Visser SP, Shaik SJ. Inorg. Biochem. 2002;91:554–567. - PubMed
    1. Mathé C, Weill CO, Mattioli TA, Berthmoieu C, Houée-Levin C, Tremey E, Nivière V. J. Biol. Chem. 2007;282:22207–22216. - PubMed
    2. Kovacs JA, Brines LM. Acc. Chem. Res. 2007;40:501–509. - PMC - PubMed
    1. McCoy JG, Bailey LJ, Bitto E, Bingman CA, Aceti DJ, Fox BG, Phillips GN., Jr Proc. Nat. Acad. Sci. 2006;103:3084–3089. - PMC - PubMed
    1. Joseph CA, Moroney MJ. Chem. Commun. 2007:3338–3349. - PubMed
    2. Aluri S, de Visser SP. J. Am. Chem. Soc. 2007;129:14846–14847. - PubMed
    3. We S, Wu X, Wei L, Tang D, Sun P, Bartlam M, Rao Z. J. Biol. Chem. 2007;282:3391–3402. - PubMed
    4. Simmons CR, Krishnamoorthy K, Granett SL, Shuller DJ, Dominy JE, Jr, Begley TP, Stipanuk MH, Karplus PA. Biochemistry. 2008;47:11390–11392. - PMC - PubMed

Publication types